1,4-Benzodiazepines Hydrogenated 1,4-benzodiazepines

Industry

CPC
C07D243/14

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C07Organic chemistry C07DHETEROCYCLIC COMPOUNDS C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms

Current Industry

C07D243/141,4-Benzodiazepines Hydrogenated 1,4-benzodiazepines

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Inhibitors of EGFR and methods of use thereof
- Patent number 12,161,649
- Issue date Dec 10, 2024
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic 1,4-diazepanones and therapeutic uses thereof
- Patent number 11,981,644
- Issue date May 14, 2024
- Cytokinetics, Inc.
- Bradley P. Morgan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of Alzheimer's disease
- Patent number 11,939,302
- Issue date Mar 26, 2024
- The Governors of the University of Alberta
- James A. Nieman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
- Patent number 11,891,365
- Issue date Feb 6, 2024
- Valo Health, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Metabotropic glutamate receptor negative allosteric modulators (NAM...
- Patent number 11,447,453
- Issue date Sep 20, 2022
- Sanford Burnham Prebys Medical Discovery Institute
- Nicholas David Peter Cosford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Alcoxyamino derivatives for treating pain and pain related conditions
- Patent number 11,401,270
- Issue date Aug 2, 2022
- ESTEVE PHARMACEUTICALS, S.A.
- Carmen Almansa-Rosales
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
- Patent number 11,279,681
- Issue date Mar 22, 2022
- Valo Health, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
- Patent number 11,274,084
- Issue date Mar 15, 2022
- Valo Health, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
- Patent number 11,274,085
- Issue date Mar 15, 2022
- Valo Health, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic compounds and uses thereof
- Patent number 11,168,070
- Issue date Nov 9, 2021
- Genentech, Inc.
- Patrick Cyr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Synthesis of trans-8-chloro-5-methyl-1-[4-(pyridin-2-yloxy)-cyclohe...
- Patent number 11,040,977
- Issue date Jun 22, 2021
- HOFFMANN-LA ROCHE INC.
- Benno Rothenhaeusler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
- Patent number 10,988,450
- Issue date Apr 27, 2021
- Valo Early Discovery, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of KRAS G12C mutant proteins
- Patent number 10,975,071
- Issue date Apr 13, 2021
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
- Patent number 10,829,461
- Issue date Nov 10, 2020
- Valo Early Discovery, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
- Patent number 10,829,462
- Issue date Nov 10, 2020
- Valo Early Discovery, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
- Patent number 10,822,316
- Issue date Nov 3, 2020
- Valo Early Discovery, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryldiazepine derivatives as RSV inhibitors
- Patent number 10,752,598
- Issue date Aug 25, 2020
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic compounds and uses thereof
- Patent number 10,696,655
- Issue date Jun 30, 2020
- Genentech, Inc.
- Patrick Cyr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Clostridium difficile toxin inhibitors
- Patent number 10,669,242
- Issue date Jun 2, 2020
- Venenum Biodesign, LLC
- Jeffrey J. Letourneau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Metabotropic glutamate receptor negative allosteric modulators (NAM...
- Patent number 10,597,367
- Issue date Mar 24, 2020
- Sanford Burnham Prebys Medical Discovery Institute
- Nicholas David Peter Cosford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrrolobenzodiazepines and conjugates thereof
- Patent number 10,526,294
- Issue date Jan 7, 2020
- Mersana Therapeutics, Inc.
- Joshua D. Thomas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
- Patent number 10,513,501
- Issue date Dec 24, 2019
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
- Patent number 10,501,424
- Issue date Dec 10, 2019
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
- Patent number 10,494,351
- Issue date Dec 3, 2019
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
- Patent number 10,494,352
- Issue date Dec 3, 2019
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
- Patent number 10,494,353
- Issue date Dec 3, 2019
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
- Patent number 10,494,354
- Issue date Dec 3, 2019
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
- Patent number 10,479,772
- Issue date Nov 19, 2019
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
- Patent number 10,472,337
- Issue date Nov 12, 2019
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
- Patent number 10,464,909
- Issue date Nov 5, 2019
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Compounds for the Treatment of Alzheimer's Disease
- Publication number 20240376059
- Publication date Nov 14, 2024
- The Governors of the University of Alberta
- James A. Nieman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BICYCLIC 1,4-DIAZEPANONES AND THERAPEUTIC USES THEREOF
- Publication number 20240368091
- Publication date Nov 7, 2024
- Cytokinetics, Inc.
- Bradley P. MORGAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POTASSIUM CHANNEL MODULATOR, COMPOSITION AND APPLICATION
- Publication number 20240317689
- Publication date Sep 26, 2024
- NEUSHEN THERAPEUTICS (SHANGHAI) CO., LTD
- Miao HU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DEUTERATED 1,4-BENZODIAZEPINE-2,5-DIONE COMPOUND AND USE THEREOF
- Publication number 20240002353
- Publication date Jan 4, 2024
- NINGBO COMBIREG PHARMACEUTICAL TECHNOLOGY CO., LTD.
- Gang LIU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METABOTROPIC GLUTAMATE RECEPTOR NEGATIVE ALLOSTERIC MODULATORS (NAM...
- Publication number 20230113588
- Publication date Apr 13, 2023
- SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
- Nicholas David Peter COSFORD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BICYCLIC 1,4-DIAZEPANONES AND THERAPEUTIC USES THEREOF
- Publication number 20230083960
- Publication date Mar 16, 2023
- Cytokinetics, Inc.
- Bradley P. MORGAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-ALKYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
- Publication number 20220363651
- Publication date Nov 17, 2022
- Valo Early Discovery, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-ARYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
- Publication number 20220204461
- Publication date Jun 30, 2022
- Valo Health, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the Treatment of Alzheimer's Disease
- Publication number 20220119356
- Publication date Apr 21, 2022
- The Governors of the University of Alberta
- James A. Nieman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF EGFR AND METHODS OF USE THEREOF
- Publication number 20210346395
- Publication date Nov 11, 2021
- Dana-Farber Cancer Institute, Inc.
- NATHANAEL S. GRAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SYNTHESIS OF TRANS-8-CHLORO-5-METHYL-1 -[4-(PYRIDIN-2-YLOXY)-CYCLOH...
- Publication number 20210284648
- Publication date Sep 16, 2021
- HOFFMANN-LA ROCHE INC.
- Benno Rothenhaeusler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION COMPOSITIONS COMPRISING BISFLUOROALKYL-1,4- BENZODIAZEP...
- Publication number 20210040050
- Publication date Feb 11, 2021
- Ayala Pharmaceuticals Inc.
- Matti Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3-ALKYL BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
- Publication number 20210009539
- Publication date Jan 14, 2021
- Valo Early Discovery, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-ARYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
- Publication number 20210009538
- Publication date Jan 14, 2021
- Valo Early Discovery, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-ARYL-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
- Publication number 20210009540
- Publication date Jan 14, 2021
- Valo Early Discovery, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC COMPOUNDS AND USES THEREOF
- Publication number 20200399244
- Publication date Dec 24, 2020
- Genentech, Inc.
- Patrick Cyr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METABOTROPIC GLUTAMATE RECEPTOR NEGATIVE ALLOSTERIC MODULATORS (NAM...
- Publication number 20200347021
- Publication date Nov 5, 2020
- SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
- Nicholas David Peter COSFORD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEW ALCOXYAMINO DERIVATIVES FOR TREATING PAIN AND PAIN RELATED COND...
- Publication number 20200299297
- Publication date Sep 24, 2020
- ESTEVE PHARMACEUTICALS, S.A.
- Carmen ALMANSA-ROSALES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-ALKYL BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
- Publication number 20200055830
- Publication date Feb 20, 2020
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-ARYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
- Publication number 20200048211
- Publication date Feb 13, 2020
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-ARYL-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
- Publication number 20200048212
- Publication date Feb 13, 2020
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-ALKYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
- Publication number 20200002298
- Publication date Jan 2, 2020
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SYNTHESIS OF TRANS-8-CHLORO-5-METHYL-1 -[4-(PYRIDIN-2-YLOXY)-CYCLOH...
- Publication number 20190194210
- Publication date Jun 27, 2019
- HOFFMANN-LA ROCHE INC.
- Benno Rothenhaeusler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-ALKYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
- Publication number 20190127339
- Publication date May 2, 2019
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-ARYL-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
- Publication number 20190119235
- Publication date Apr 25, 2019
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-ALKYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
- Publication number 20190119227
- Publication date Apr 25, 2019
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-ALKYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
- Publication number 20190119230
- Publication date Apr 25, 2019
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-ARYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
- Publication number 20190119231
- Publication date Apr 25, 2019
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-ARYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
- Publication number 20190119233
- Publication date Apr 25, 2019
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-ARYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
- Publication number 20190119234
- Publication date Apr 25, 2019
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY

1,4-Benzodiazepines Hydrogenated 1,4-benzodiazepines

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Inhibitors of EGFR and methods of use thereof

Bicyclic 1,4-diazepanones and therapeutic uses thereof

Compounds for the treatment of Alzheimer's disease

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

Metabotropic glutamate receptor negative allosteric modulators (NAM...

Alcoxyamino derivatives for treating pain and pain related conditions

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

Therapeutic compounds and uses thereof

Synthesis of trans-8-chloro-5-methyl-1-[4-(pyridin-2-yloxy)-cyclohe...

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

Inhibitors of KRAS G12C mutant proteins

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

Aryldiazepine derivatives as RSV inhibitors

Therapeutic compounds and uses thereof

Clostridium difficile toxin inhibitors

Metabotropic glutamate receptor negative allosteric modulators (NAM...

Pyrrolobenzodiazepines and conjugates thereof

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

Patents Applicationslast 30 patents

Compounds for the Treatment of Alzheimer's Disease

BICYCLIC 1,4-DIAZEPANONES AND THERAPEUTIC USES THEREOF

POTASSIUM CHANNEL MODULATOR, COMPOSITION AND APPLICATION

DEUTERATED 1,4-BENZODIAZEPINE-2,5-DIONE COMPOUND AND USE THEREOF

METABOTROPIC GLUTAMATE RECEPTOR NEGATIVE ALLOSTERIC MODULATORS (NAM...

BICYCLIC 1,4-DIAZEPANONES AND THERAPEUTIC USES THEREOF

3-ALKYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS

3-ARYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS

Compounds for the Treatment of Alzheimer's Disease

INHIBITORS OF EGFR AND METHODS OF USE THEREOF

SYNTHESIS OF TRANS-8-CHLORO-5-METHYL-1 -[4-(PYRIDIN-2-YLOXY)-CYCLOH...

COMBINATION COMPOSITIONS COMPRISING BISFLUOROALKYL-1,4- BENZODIAZEP...

3-ALKYL BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS

3-ARYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS

3-ARYL-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS

THERAPEUTIC COMPOUNDS AND USES THEREOF

METABOTROPIC GLUTAMATE RECEPTOR NEGATIVE ALLOSTERIC MODULATORS (NAM...

NEW ALCOXYAMINO DERIVATIVES FOR TREATING PAIN AND PAIN RELATED COND...

3-ALKYL BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS

3-ARYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS

3-ARYL-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS

3-ALKYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS

SYNTHESIS OF TRANS-8-CHLORO-5-METHYL-1 -[4-(PYRIDIN-2-YLOXY)-CYCLOH...

3-ALKYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS

3-ARYL-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS

3-ALKYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS

3-ALKYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS

3-ARYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS

3-ARYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS

3-ARYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS